학술논문
Interferon-α2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: Results of a multi-institutional Australian randomized trial
Document Type
Article
Author
Source
In: Melanoma Research . (Melanoma Research, 1993, 3(2):133-138)
Subject
Language
English
ISSN
09608931